Why the study?
What are the recommended pharmacological strategies for preventing arterial thromboembolism in patients with specific cardiovascular and cerebrovascular conditions?
What are the recommended pharmacological strategies for preventing arterial thromboembolism in patients with specific cardiovascular and cerebrovascular conditions?
Answers are grounded in this paper and cite their sources.
This 1981 review outlines the contemporary indications for antiplatelet and anticoagulant therapies in preventing arterial thromboembolism across various high-risk patient groups.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stanford Wessler (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: